Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2007;56:1186-1188; doi:10.1136/gut.2006.118422
Copyright © 2007 BMJ Publishing Group Ltd & British Society of Gastroenterology.

COMMENTARY

Fatty liver in chronic hepatitis C infection

Fatty liver in chronic hepatitis C infection: unravelling the mechanisms

Jude A Oben1, Emma Paulon2

1 University College London, Centre for Hepatology, Royal Free Hospital, London, UK; Guy’s and St Thomas’ Hospital, London, UK
2 Institute of Hepatology, University College London, London WC1 6BT, UK

Correspondence to:
Correspondence to:
Dr Jude A Oben
Centre for Hepatology, University College London, Royal Free Hospital, London NW3 2PF; jude.oben@gstt.nhs.uk


A step closer to understanding fatty liver due to HCV

The first 150 words of the full text of this article appear below.

Chronic hepatitis C virus (HCV) infection afflicts about 200 million people worldwide and is presently the most common cause of cirrhosis and hepatocellular carcinoma in Western countries. Over the last decade, an association between HCV infection, hepatic steatosis, insulin resistance (IR) and type II diabetes has been highlighted, although the cause–effect relationship underlying the co-existence of these phenomena has yet to be completely clarified.1 These observations are important because the presence of steatosis and/or IR in chronic HCV infection appears to modulate the progression of fibrosis and the response to antiviral therapy in chronic HCV infection.2–4

Mechanisms underling steatosis development in chronic HCV infection have been demonstrated to be genotype specific, with an apparent direct steatogenic effect of genotype 3, and an IR-associated steatosis effect exerted by genotype 1.5,6 The direct steatogenic effect of HCV genotype 3 is confirmed by findings such as . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model
C Hourioux, R Patient, A Morin, E Blanchard, A Moreau, S Trassard, B Giraudeau, and P Roingeard
Gut 2007 56: 1302-1308. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs